HCPCS Level II
J9026
Injection, tarlatamab-dlle, 1 mg
Codes near J9026
These sit next to J9026 in the CMS Level II file. All J codes
- J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
- J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025Injection, azacitidine, 1 mg
- J9027Injection, clofarabine, 1 mg
- J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9030Bcg live intravesical instillation, 1 mg
- J9031Bcg (intravesical) per instillation
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 55513-0059-01 | Imdelltra | Amgen Inc | 1 |
| 55513-0077-01 | Imdelltra | Amgen Inc | 10 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.